Fa. Laszlo et al., Testosterone-secreting gonadotropin-responsive adrenal adenoma and its treatment with the antiandrogen flutamide, J ENDOC INV, 24(8), 2001, pp. 622-627
A 55-year-old woman with virilization had an appreciably elevated testoster
one level, which was not suppressed by dexamethasone, but was increased by
stimulation with human chorionic gonadotropin (hCG). Ultrasonography and co
mputed tomography revealed an adenoma 2.5-3.0 cm in diameter in the right a
drenal gland. The patient was treated with the antiandrogen flutamide in a
daily dose of 500 mg for 4 months. A substantial regression of her hirsutis
m was observed during flutamide administration, but the serum testosterone
level remained high. Right adrenalectomy was performed. Histologically, the
tumor proved to be an adrenocortical adenoma of zona reticularis type. The
adenoma tissue contained specific hCG receptors (1187 fmol/g). The steroid
concentration in the tumor tissue was examined by means of high pressure l
iquid chromatography-radioimmunoassay (HPLC-RIA). A significantly increased
testosterone content was detected, and the levels of its precursors, andro
stenedione and dehydroepiandrosterone, were also elevated. Following adrena
lectomy, serum testosterone concentration decreased to the normal level. Th
e mechanism of the inappropriate regulation in the testosterone production
of the adrenal tumor has not been fully elucidated. (J. Endocrinol. Invest.
24: 622-627, 2001) (C) 2001, Editrice Kurtis.